8037 China Biotech Services Holdings Limited HKEX · Hong Kong

China Biotech Services Holdings (8037) news

China Biotech Services Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 8037, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest China Biotech Services Holdings news

We have not published a story on China Biotech Services Holdings yet. When there is news, it will appear here.

Questions about China Biotech Services Holdings

What is the ticker symbol of China Biotech Services Holdings?

China Biotech Services Holdings Limited trades under the ticker 8037 on HKEX.

Where is China Biotech Services Holdings listed?

China Biotech Services Holdings Limited is listed on HKEX.

Which country or territory is China Biotech Services Holdings listed under?

Our directory records China Biotech Services Holdings Limited under Hong Kong.

What does China Biotech Services Holdings do?

Our directory classifies China Biotech Services Holdings Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of China Biotech Services Holdings?

The ISIN recorded for China Biotech Services Holdings Limited is BMG2152F1014.

Does aibio.space cover China Biotech Services Holdings?

aibio.space lists China Biotech Services Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to China Biotech Services Holdings?

Companies in our directory listed in the same country and business area as China Biotech Services Holdings: Sanai Health Industry Group Company, China Resources Pharmaceutical Group, InSilico Medicine Cayman TopCo, Shenzhen Neptunus Interlong Bio-Technique Co., Regencell Bioscience Holdings, Pak Fah Yeow International.

Investor discussion: China Biotech Services Holdings

Members talk about China Biotech Services Holdings (8037). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at China Biotech Services Holdings, newest first. Each line links the filing it comes from.

Aug 13, 2026Mergers
Transaction under the Listing Rules: COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Aug 7, 2026Mergers
Transaction under the Listing Rules: COMPLETION OF DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR. Source
Jun 30, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Jun 29, 2026Mergers
Transaction under the Listing Rules: GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Jun 26, 2026Mergers
Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Jun 26, 2026Mergers
Transaction under the Listing Rules: UPDATES ON DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR. Source
Jun 9, 2026Mergers
Transaction under the Listing Rules: GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Jun 2, 2026Mergers
Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
May 22, 2026Financings
Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source
May 18, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED. Source
Feb 23, 2026Financings
Share or debt issue: (1) COMPLETION OF ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE; AND (2) ADJUSTMENT RELATING TO THE OUTSTANDING 2024 CONVERTIBLE BONDS. Source
Jan 22, 2026Financings
Share or debt issue: (1) PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE; AND (2) NOTICE OF SPECIAL GENERAL MEETING. Source
Dec 29, 2025Financings
Share or debt issue: PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE. Source
Sep 8, 2025Mergers
Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR. Source
Jul 13, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR. Source
May 7, 2025Financings
Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; AND (3) NOTICE OF ANNUAL GENERAL MEETING. Source
Mar 31, 2025Mergers
Transaction under the Listing Rules: UPDATE ANNOUNCEMENT IN RELATION TO (1) DISCLOSEABLE TRANSACTION IN RELATION TO THE CAPITAL INJECTION IN AND DEEMED DISPOSAL OF EQUITY INTEREST IN PENGBO (HAINAN) MEDICAL TECHNOLOGY CO., LTD#; AND (2) DISCLOSEABLE TRANSACTION IN RELATION TO THE GRANT OF THE REPURCHASE RIGHTS. Source
Feb 27, 2025Mergers
Transaction under the Listing Rules: (1) DISCLOSEABLE TRANSACTION IN RELATION TO THE CAPITAL INJECTION IN AND DEEMED DISPOSAL OF EQUITY INTEREST IN PENGBO (HAINAN) MEDICAL TECHNOLOGY CO., LTD#; AND (2) DISCLOSEABLE TRANSACTION IN RELATION TO THE GRANT OF THE REPURCHASE RIGHTS. Source
Dec 27, 2024Financings
Share or debt issue: COMPLETION OF ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE. Source
Dec 17, 2024Financings
Share or debt issue: ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE. Source
Nov 15, 2024Mergers
Transaction under the Listing Rules: EXPIRY OF LONG STOP DATE AND LAPSE OF (1) MAJOR TRANSACTION IN RELATION TO THE CAPITAL INJECTION IN AND DEEMED DISPOSAL OF EQUITY INTEREST IN PENGBO (HAINAN) MEDICAL TECHNOLOGY CO., LTD#; AND (2) MAJOR TRANSACTION IN RELATION TO THE GRANT OF THE REPURCHASE RIGHTS. Source
Nov 4, 2024Mergers
Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF THE (1) MAJOR TRANSACTION IN RELATION TO THE CAPITAL INJECTION IN AND DEEMED DISPOSAL OF EQUITY INTEREST IN PENGBO (HAINAN) MEDICAL TECHNOLOGY CO., LTD#; AND (2) MAJOR TRANSACTION IN RELATION TO THE GRANT OF THE REPURCHASE RIGHTS. Source

Press releases

Headlines of China Biotech Services Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

Sep 29, 2026HKEXnews
Notification Letter to Non-Registered Shareholders
Sep 29, 2026HKEXnews
Notification Letter to Registered Shareholders and Reply Form
Sep 2, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT IN RELATION TO CROSS-BORDER BNCT CLINICAL SERVICES
Aug 28, 2026HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026
Aug 13, 2026HKEXnews
COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
Aug 12, 2026HKEXnews
POSITIVE PROFIT ALERT
Aug 12, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - MASTER COLLABORATION AGREEMENT WITH STELLA PHARMA CORPORATION IN RELATION TO COMMERCIALISATION OF BNCT DRUG
Aug 7, 2026HKEXnews
COMPLETION OF DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR
Aug 3, 2026HKEXnews
COMPANY INFORMATION SHEET
Aug 3, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF INITIAL FOLLOW-UP FINDINGS OF BORON NEUTRON CAPTURE THERAPY AT THE 22ND CONGRESS ON NEUTRON CAPTURE THERAPY
Jun 30, 2026HKEXnews
Major Transaction
Jun 30, 2026HKEXnews
MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
Jun 29, 2026HKEXnews
GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
Jun 26, 2026HKEXnews
FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
Jun 26, 2026HKEXnews
UPDATES ON DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR
Jun 16, 2026HKEXnews
SUPPLEMENTAL ANNOUNCEMENT TO THE UPDATE ON EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY AND SUBSCRIPTION OF SHARES IN A SUBSIDIARY
Jun 15, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 JUNE 2026
Jun 9, 2026HKEXnews
GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
Jun 2, 2026HKEXnews
SUPPLEMENTAL ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND PREMIER MEDICARE SERVICES LIMITED
May 22, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:8037 on TradingView.

Listing details

Company: China Biotech Services Holdings Limited
Ticker: 8037
Listing: HKEX
Country or territory: Hong Kong
Business scope: Pharmaceuticals: Major
ISIN: BMG2152F1014
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction